### Response:
#### Step 1:
The HIPAA regulation ID 164.504(e)(2)(ii)(E) pertains to the permissible uses and disclosures for health care operations. It specifically addresses the use of protected health information for activities such as quality assessment and improvement activities, population-based activities relating to improving health or reducing health care costs, and case management and care coordination.

#### Step 2:
After reviewing the case, it is evident that the new policy implemented by the DHHR requiring patient advocates to obtain signed releases before accessing patient health records is in alignment with the HIPAA Privacy Rule. The rule emphasizes the importance of patient privacy and the need for appropriate authorization before disclosing protected health information.

#### Step 3:
**Forbid**

In this case, the HIPAA Privacy Rule forbids the patient advocates from having unrestricted access to patient health records without the necessary signed releases from the patients or their legal representatives. This requirement ensures that patient privacy is upheld and that access to sensitive health information is controlled and authorized appropriately.